Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Abpro Holdings Inc. (ABP : NSDQ)

• Company Description    Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $0.19 Daily Weekly Monthly 20 Day Moving Average: 3,033,472 shares Shares Outstanding: 60.79 (millions) Market Capitalization: $11.84 (millions) Beta: 0.00 52 Week High: $13.00 52 Week Low: $0.15 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.82% -18.98% 12 Week -24.53% -36.52% Year To Date -89.12% -89.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 68 Cummings Park Drive - Woburn,MA 01801 USA ph: 1-800-396-5890 fax: - None https://abpro.com

• General Corporate Information    Officers Miles Suk - Chief Executive Officer and Chairman of the Board Anthony D. Eisenberg - Director Soo Young Lee - Director Ian McDonald - Director Joanna Lord - Director Peer Information Abpro Holdings Inc. (CORR.) Abpro Holdings Inc. (RSPI) Abpro Holdings Inc. (CGXP) Abpro Holdings Inc. (BGEN) Abpro Holdings Inc. (GTBP) Abpro Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 000847103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/21/25 Share - Related Items Shares Outstanding: 60.79 Most Recent Split Date: (:1) Beta: 0.00 Market Capitalization: $11.84 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/21/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 50.00% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -198.95 12/31/24 - -103.50 Current Ratio 06/30/25 - - 03/31/25 - 0.11 12/31/24 - 0.19 Quick Ratio 06/30/25 - - 03/31/25 - 0.11 12/31/24 - 0.19 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - -6,423.50 12/31/24 - -3,951.91 Book Value 06/30/25 - - 03/31/25 - -0.34 12/31/24 - -0.29 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©